- Study Type: Vaccine
A major goal of systems biology is the development of models that accurately predict responses to perturbation. Constructing such models requires the collection of dense measurements of system states, yet transformation of data into predictive constructs remains a challenge. To begin to model human immunity, we analyzed immune parameters in depth both at baseline and in response to influenza vaccination.Peripheral blood mononuclear cell transcriptomes, serum titers, cell subpopulation frequencies, and B cell responses were assessed in 63 individuals before and after vaccination and were used to develop a systematic framework to dissect inter- and intra-individual variation and build predictive models of postvaccination antibody responses.Strikingly, independent of age and pre-existing antibody titers, accurate models could be constructed using pre-perturbation cell populations alone, which were validated using independent baseline time points. Most of the parameters contributing to prediction delineated temporally stable baseline differences across individuals, raising the prospect of immune monitoring before intervention.
--
According to CHI protocol 09-H1-0239, PBMC samples from 63 healthy voluntiers were collected 7 days prior to vaccination, immediately before vaccination (day0), and at 3 time points (day1, day7 and day70) post vaccination.The CHI Consortium
--
--
--
--
Sample ID | !Sample Title | Age | Gender | tissue | group |
---|---|---|---|---|---|
GSM1147758 | PBMC_200_day0 | 24 | male | peripheral blood mononuclear cells (PBMC) | day 0 |
GSM1147759 | PBMC_200_day1 | 24 | male | peripheral blood mononuclear cells (PBMC) | day 1 |
GSM1147760 | PBMC_200_day70 | 24 | male | peripheral blood mononuclear cells (PBMC) | day 70 |
GSM1147761 | PBMC_200_day7 | 24 | male | peripheral blood mononuclear cells (PBMC) | day 7 |
GSM1147762 | PBMC_200_day-7 | 24 | male | peripheral blood mononuclear cells (PBMC) | day -7 |
All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.
Sample ID | !Sample Title | Age | Gender | Tissue | Group | Mn Mfc Class | Mn A Uruguay 716 2007 | Ethnicty | Elispot Memory H1n1 Igg | Elispot Effector Total Igg | Mn B Brisbane 60 2001 | Elispot Memory Seasonal Igg | Elispot Memory Total Igg | Elispot Effector H1n1 Igg | Mn Adjmfc Class | Mn A Brisbane 59 2007 | Elispot Effector Seasonal Igg | Mn A Ca 07 Swine | Individual id | Sample collection time |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSM1147758 | PBMC_200_day0 |
24 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
160 |
White |
44 |
533.5 |
40 |
167 |
45128 |
0 |
0 |
80 |
0 |
40 |
200 |
immediately before vaccination (day0) |
GSM1147759 | PBMC_200_day1 |
24 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
200 |
1 day post vaccination (day1) |
GSM1147760 | PBMC_200_day70 |
24 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
320 |
White |
66 |
NA |
160 |
172 |
37356 |
NA |
0 |
160 |
NA |
2560 |
200 |
70 days post vaccination (day70) |
GSM1147761 | PBMC_200_day7 |
24 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
320 |
White |
NA |
6950 |
80 |
NA |
NA |
4408.5 |
0 |
160 |
370 |
5120 |
200 |
7 days post vaccination (day7) |
GSM1147762 | PBMC_200_day-7 |
24 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
200 |
7 days prior to vaccination (day-7) |
GSM1147763 | PBMC_201_day0 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
0 |
80 |
White |
20 |
800 |
80 |
23 |
22306 |
0 |
0 |
160 |
0 |
<20 |
201 |
immediately before vaccination (day0) |
GSM1147764 | PBMC_201_day1 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
0 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
201 |
1 day post vaccination (day1) |
GSM1147765 | PBMC_201_day70 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
0 |
320 |
White |
53 |
NA |
80 |
69 |
19593 |
NA |
0 |
160 |
NA |
20 |
201 |
70 days post vaccination (day70) |
GSM1147766 | PBMC_201_day7 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
0 |
640 |
White |
NA |
1533.5 |
160 |
NA |
NA |
110 |
0 |
160 |
368.5 |
20 |
201 |
7 days post vaccination (day7) |
GSM1147767 | PBMC_201_day-7 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
0 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
201 |
7 days prior to vaccination (day-7) |
GSM1147768 | PBMC_202_day0 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
2 |
40 |
Asain |
9 |
883.5 |
<20 |
44 |
70120 |
0 |
2 |
<20 |
0 |
<20 |
202 |
immediately before vaccination (day0) |
GSM1147769 | PBMC_202_day1 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
2 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
202 |
1 day post vaccination (day1) |
GSM1147770 | PBMC_202_day70 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
2 |
1280 |
Asain |
35 |
NA |
320 |
347 |
46483 |
NA |
2 |
1280 |
NA |
160 |
202 |
70 days post vaccination (day70) |
GSM1147771 | PBMC_202_day7 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
2 |
320 |
Asain |
NA |
6250 |
320 |
NA |
NA |
606.5 |
2 |
320 |
2861.5 |
320 |
202 |
7 days post vaccination (day7) |
GSM1147772 | PBMC_202_day-7 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
2 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
202 |
7 days prior to vaccination (day-7) |
GSM1147773 | PBMC_204_day0 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
2 |
40 |
White |
0 |
2433.5 |
<20 |
17 |
40741 |
0 |
1 |
20 |
0 |
<20 |
204 |
immediately before vaccination (day0) |
GSM1147774 | PBMC_204_day1 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
2 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
204 |
1 day post vaccination (day1) |
GSM1147775 | PBMC_204_day70 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
2 |
5120 |
White |
32 |
NA |
80 |
392 |
56833 |
NA |
1 |
1280 |
NA |
320 |
204 |
70 days post vaccination (day70) |
GSM1147776 | PBMC_204_day7 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
2 |
640 |
White |
NA |
25000 |
40 |
NA |
NA |
2933.5 |
1 |
160 |
6833.5 |
640 |
204 |
7 days post vaccination (day7) |
GSM1147777 | PBMC_204_day-7 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
2 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
204 |
7 days prior to vaccination (day-7) |
GSM1147778 | PBMC_205_day0 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
2 |
<20 |
White |
0 |
333 |
<20 |
0 |
9220 |
0 |
2 |
<20 |
0 |
40 |
205 |
immediately before vaccination (day0) |
GSM1147779 | PBMC_205_day1 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
2 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
205 |
1 day post vaccination (day1) |
GSM1147780 | PBMC_205_day70 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
2 |
40 |
White |
50 |
NA |
40 |
138 |
18014 |
NA |
2 |
1280 |
NA |
2560 |
205 |
70 days post vaccination (day70) |
GSM1147781 | PBMC_205_day7 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
2 |
80 |
White |
NA |
15050 |
160 |
NA |
NA |
5583.5 |
2 |
2560 |
4683.5 |
8000 |
205 |
7 days post vaccination (day7) |
GSM1147782 | PBMC_205_day-7 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
2 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
205 |
7 days prior to vaccination (day-7) |
GSM1147783 | PBMC_206_day0 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
NA |
1280 |
Asain |
96 |
900 |
80 |
276 |
54889 |
0 |
NA |
160 |
5 |
160 |
206 |
immediately before vaccination (day0) |
GSM1147784 | PBMC_206_day1 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
NA |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
206 |
1 day post vaccination (day1) |
GSM1147785 | PBMC_206_day70 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
NA |
2560 |
Asain |
121 |
NA |
80 |
267 |
38095 |
NA |
NA |
160 |
NA |
640 |
206 |
70 days post vaccination (day70) |
GSM1147786 | PBMC_206_day7 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
NA |
2560 |
Asain |
NA |
1833.5 |
160 |
NA |
NA |
1160 |
NA |
320 |
88.5 |
640 |
206 |
7 days post vaccination (day7) |
GSM1147787 | PBMC_206_day-7 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
NA |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
206 |
7 days prior to vaccination (day-7) |
GSM1147788 | PBMC_207_day0 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
2 |
320 |
White |
3 |
1933 |
<20 |
31 |
18062 |
0 |
2 |
20 |
0 |
<20 |
207 |
immediately before vaccination (day0) |
GSM1147789 | PBMC_207_day1 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
2 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
207 |
1 day post vaccination (day1) |
GSM1147790 | PBMC_207_day70 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
2 |
5120 |
White |
27 |
NA |
80 |
179 |
26667 |
NA |
2 |
2560 |
NA |
320 |
207 |
70 days post vaccination (day70) |
GSM1147791 | PBMC_207_day-7 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
2 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
207 |
7 days prior to vaccination (day-7) |
GSM1147792 | PBMC_209_day0 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
2 |
40 |
White |
0 |
250 |
40 |
28 |
8576 |
0 |
2 |
20 |
5 |
<20 |
209 |
immediately before vaccination (day0) |
GSM1147793 | PBMC_209_day1 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
2 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
209 |
1 day post vaccination (day1) |
GSM1147794 | PBMC_209_day70 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
2 |
2560 |
White |
6 |
NA |
1280 |
101 |
11111 |
NA |
2 |
5120 |
NA |
1280 |
209 |
70 days post vaccination (day70) |
GSM1147795 | PBMC_209_day-7 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
2 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
209 |
7 days prior to vaccination (day-7) |
GSM1147796 | PBMC_212_day0 |
55 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
2 |
<20 |
White |
0 |
450 |
640 |
2 |
4054 |
0 |
2 |
<20 |
0 |
<20 |
212 |
immediately before vaccination (day0) |
GSM1147797 | PBMC_212_day1 |
55 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
2 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
212 |
1 day post vaccination (day1) |
GSM1147798 | PBMC_212_day70 |
55 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
2 |
5120 |
White |
15 |
NA |
1280 |
92 |
2778 |
NA |
2 |
40 |
NA |
160 |
212 |
70 days post vaccination (day70) |
GSM1147799 | PBMC_212_day7 |
55 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
2 |
320 |
White |
NA |
4000 |
1280 |
NA |
NA |
1676.5 |
2 |
<20 |
2866.5 |
20 |
212 |
7 days post vaccination (day7) |
GSM1147800 | PBMC_212_day-7 |
55 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
2 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
212 |
7 days prior to vaccination (day-7) |
GSM1147801 | PBMC_213_day0 |
30 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
<20 |
Asain |
0 |
567 |
<20 |
14 |
32079 |
0 |
1 |
<20 |
5 |
<20 |
213 |
immediately before vaccination (day0) |
GSM1147802 | PBMC_213_day1 |
30 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
213 |
1 day post vaccination (day1) |
GSM1147803 | PBMC_213_day70 |
30 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
640 |
Asain |
81 |
NA |
320 |
931 |
38750 |
NA |
1 |
80 |
NA |
40 |
213 |
70 days post vaccination (day70) |
GSM1147804 | PBMC_213_day7 |
30 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
640 |
Asain |
NA |
12667 |
160 |
NA |
NA |
1103.5 |
1 |
80 |
2665 |
160 |
213 |
7 days post vaccination (day7) |
GSM1147805 | PBMC_213_day-7 |
30 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
213 |
7 days prior to vaccination (day-7) |
GSM1147806 | PBMC_215_day0 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
640 |
Asain |
10 |
1417 |
640 |
71 |
49133 |
5 |
2 |
1280 |
0 |
20 |
215 |
immediately before vaccination (day0) |
GSM1147807 | PBMC_215_day1 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
215 |
1 day post vaccination (day1) |
GSM1147808 | PBMC_215_day70 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
640 |
Asain |
76 |
NA |
640 |
218 |
60963 |
NA |
2 |
1280 |
NA |
5120 |
215 |
70 days post vaccination (day70) |
GSM1147809 | PBMC_215_day7 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
640 |
Asain |
NA |
12000 |
640 |
NA |
NA |
3150 |
2 |
640 |
1760 |
2560 |
215 |
7 days post vaccination (day7) |
GSM1147810 | PBMC_215_day-7 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
215 |
7 days prior to vaccination (day-7) |
GSM1147811 | PBMC_217_day0 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
20 |
White |
11 |
667 |
<20 |
109 |
62185 |
0 |
1 |
160 |
0 |
<20 |
217 |
immediately before vaccination (day0) |
GSM1147812 | PBMC_217_day1 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
217 |
1 day post vaccination (day1) |
GSM1147813 | PBMC_217_day70 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
320 |
White |
317 |
NA |
160 |
445 |
46779 |
NA |
1 |
640 |
NA |
640 |
217 |
70 days post vaccination (day70) |
GSM1147814 | PBMC_217_day7 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
640 |
White |
NA |
1133.5 |
320 |
NA |
NA |
543.5 |
1 |
2560 |
1111.5 |
1280 |
217 |
7 days post vaccination (day7) |
GSM1147815 | PBMC_217_day-7 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
217 |
7 days prior to vaccination (day-7) |
GSM1147816 | PBMC_218_day0 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
80 |
Hispanic |
0 |
683.5 |
20 |
126 |
45939 |
0 |
1 |
160 |
0 |
<20 |
218 |
immediately before vaccination (day0) |
GSM1147817 | PBMC_218_day1 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
Hispanic |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
218 |
1 day post vaccination (day1) |
GSM1147818 | PBMC_218_day70 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
1280 |
Hispanic |
53 |
NA |
80 |
365 |
47261 |
NA |
1 |
320 |
NA |
640 |
218 |
70 days post vaccination (day70) |
GSM1147819 | PBMC_218_day7 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
5120 |
Hispanic |
NA |
5917 |
320 |
NA |
NA |
2081.5 |
1 |
1280 |
1028.5 |
2560 |
218 |
7 days post vaccination (day7) |
GSM1147820 | PBMC_218_day-7 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
Hispanic |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
218 |
7 days prior to vaccination (day-7) |
GSM1147821 | PBMC_221_day0 |
24 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
80 |
White |
8 |
200 |
<20 |
149 |
32093 |
0 |
1 |
2560 |
5 |
40 |
221 |
immediately before vaccination (day0) |
GSM1147822 | PBMC_221_day1 |
24 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
221 |
1 day post vaccination (day1) |
GSM1147823 | PBMC_221_day7 |
24 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
320 |
White |
NA |
13650 |
80 |
NA |
NA |
3783.5 |
1 |
2560 |
1266.5 |
5120 |
221 |
7 days post vaccination (day7) |
GSM1147824 | PBMC_221_day-7 |
24 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
221 |
7 days prior to vaccination (day-7) |
GSM1147825 | PBMC_222_day0 |
25 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
1280 |
Asain |
246 |
283.5 |
160 |
446 |
35338 |
0 |
1 |
20 |
0 |
20 |
222 |
immediately before vaccination (day0) |
GSM1147826 | PBMC_222_day1 |
25 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
222 |
1 day post vaccination (day1) |
GSM1147827 | PBMC_222_day70 |
25 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
5120 |
Asain |
256 |
NA |
160 |
829 |
44222 |
NA |
1 |
160 |
NA |
640 |
222 |
70 days post vaccination (day70) |
GSM1147828 | PBMC_222_day7 |
25 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
5120 |
Asain |
NA |
1916.5 |
320 |
NA |
NA |
1250 |
1 |
80 |
568.5 |
1280 |
222 |
7 days post vaccination (day7) |
GSM1147829 | PBMC_222_day-7 |
25 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
222 |
7 days prior to vaccination (day-7) |
GSM1147830 | PBMC_224_day1 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
224 |
1 day post vaccination (day1) |
GSM1147831 | PBMC_224_day70 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
2560 |
White |
62 |
NA |
5120 |
376 |
24419 |
NA |
1 |
2560 |
NA |
80 |
224 |
70 days post vaccination (day70) |
GSM1147832 | PBMC_224_day7 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
1280 |
White |
NA |
3400 |
5120 |
NA |
NA |
316.5 |
1 |
1280 |
1926.5 |
20 |
224 |
7 days post vaccination (day7) |
GSM1147833 | PBMC_224_day-7 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
224 |
7 days prior to vaccination (day-7) |
GSM1147834 | PBMC_226_day0 |
26 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
NA |
160 |
White |
109 |
467 |
320 |
174 |
11526 |
0 |
NA |
40 |
0 |
40 |
226 |
immediately before vaccination (day0) |
GSM1147835 | PBMC_226_day1 |
26 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
NA |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
226 |
1 day post vaccination (day1) |
GSM1147836 | PBMC_226_day70 |
26 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
NA |
640 |
White |
144 |
NA |
320 |
391 |
20115 |
NA |
NA |
80 |
NA |
160 |
226 |
70 days post vaccination (day70) |
GSM1147837 | PBMC_226_day7 |
26 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
NA |
1280 |
White |
NA |
4383.5 |
640 |
NA |
NA |
2305 |
NA |
320 |
401.5 |
320 |
226 |
7 days post vaccination (day7) |
GSM1147838 | PBMC_226_day-7 |
26 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
NA |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
226 |
7 days prior to vaccination (day-7) |
GSM1147839 | PBMC_227_day0 |
33 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
320 |
White |
2 |
1633 |
40 |
51 |
22587 |
0 |
1 |
<20 |
0 |
40 |
227 |
immediately before vaccination (day0) |
GSM1147840 | PBMC_227_day1 |
33 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
227 |
1 day post vaccination (day1) |
GSM1147841 | PBMC_227_day70 |
33 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
2560 |
White |
58 |
NA |
160 |
269 |
20968 |
NA |
1 |
80 |
NA |
320 |
227 |
70 days post vaccination (day70) |
GSM1147842 | PBMC_227_day7 |
33 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
10240 |
White |
NA |
1833.5 |
40 |
NA |
NA |
611.5 |
1 |
80 |
586.5 |
160 |
227 |
7 days post vaccination (day7) |
GSM1147843 | PBMC_227_day-7 |
33 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
227 |
7 days prior to vaccination (day-7) |
GSM1147844 | PBMC_228_day0 |
24 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
<20 |
White |
12 |
683.5 |
160 |
35 |
15205 |
0 |
2 |
40 |
0 |
<20 |
228 |
immediately before vaccination (day0) |
GSM1147845 | PBMC_228_day1 |
24 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
228 |
1 day post vaccination (day1) |
GSM1147846 | PBMC_228_day70 |
24 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
1280 |
White |
37 |
NA |
640 |
106 |
22736 |
NA |
2 |
1280 |
NA |
640 |
228 |
70 days post vaccination (day70) |
GSM1147847 | PBMC_228_day7 |
24 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
320 |
White |
NA |
6250 |
320 |
NA |
NA |
723.5 |
2 |
320 |
3200 |
160 |
228 |
7 days post vaccination (day7) |
GSM1147848 | PBMC_228_day-7 |
24 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
228 |
7 days prior to vaccination (day-7) |
GSM1147849 | PBMC_229_day0 |
56 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
<20 |
White |
8 |
266.5 |
<20 |
70 |
14257 |
0 |
0 |
<20 |
0 |
<20 |
229 |
immediately before vaccination (day0) |
GSM1147850 | PBMC_229_day1 |
56 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
229 |
1 day post vaccination (day1) |
GSM1147851 | PBMC_229_day70 |
56 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
20 |
White |
22 |
NA |
20 |
73 |
13333 |
NA |
0 |
<20 |
NA |
320 |
229 |
70 days post vaccination (day70) |
GSM1147852 | PBMC_229_day7 |
56 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
40 |
White |
NA |
433.5 |
40 |
NA |
NA |
5 |
0 |
20 |
90 |
20 |
229 |
7 days post vaccination (day7) |
GSM1147853 | PBMC_229_day-7 |
56 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
229 |
7 days prior to vaccination (day-7) |
GSM1147854 | PBMC_230_day0 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
2 |
40 |
White |
156 |
683.5 |
<20 |
468 |
38788 |
0 |
1 |
<20 |
0 |
160 |
230 |
immediately before vaccination (day0) |
GSM1147855 | PBMC_230_day1 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
2 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
230 |
1 day post vaccination (day1) |
GSM1147856 | PBMC_230_day70 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
2 |
1280 |
White |
441 |
NA |
640 |
695 |
60417 |
NA |
1 |
160 |
NA |
2560 |
230 |
70 days post vaccination (day70) |
GSM1147857 | PBMC_230_day7 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
2 |
320 |
White |
NA |
15333.5 |
160 |
NA |
NA |
3991.5 |
1 |
40 |
2756.5 |
5120 |
230 |
7 days post vaccination (day7) |
GSM1147858 | PBMC_230_day-7 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
2 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
230 |
7 days prior to vaccination (day-7) |
GSM1147859 | PBMC_231_day0 |
31 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
160 |
Asain |
4 |
1817 |
160 |
83 |
41394 |
0 |
1 |
160 |
0 |
<20 |
231 |
immediately before vaccination (day0) |
GSM1147860 | PBMC_231_day1 |
31 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
231 |
1 day post vaccination (day1) |
GSM1147861 | PBMC_231_day70 |
31 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
320 |
Asain |
27 |
NA |
160 |
157 |
26961 |
NA |
1 |
640 |
NA |
640 |
231 |
70 days post vaccination (day70) |
GSM1147862 | PBMC_231_day7 |
31 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
1280 |
Asain |
NA |
23333 |
320 |
NA |
NA |
5863.5 |
1 |
640 |
1386.5 |
320 |
231 |
7 days post vaccination (day7) |
GSM1147863 | PBMC_231_day-7 |
31 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
231 |
7 days prior to vaccination (day-7) |
GSM1147864 | PBMC_232_day0 |
44 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
80 |
Asain |
1 |
1217 |
80 |
128 |
36732 |
0 |
1 |
40 |
0 |
<20 |
232 |
immediately before vaccination (day0) |
GSM1147865 | PBMC_232_day1 |
44 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
232 |
1 day post vaccination (day1) |
GSM1147866 | PBMC_232_day70 |
44 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
1280 |
Asain |
104 |
NA |
80 |
755 |
45808 |
NA |
1 |
320 |
NA |
<20 |
232 |
70 days post vaccination (day70) |
GSM1147867 | PBMC_232_day7 |
44 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
20480 |
Asain |
NA |
3100 |
160 |
NA |
NA |
188.5 |
1 |
5120 |
1528.5 |
<20 |
232 |
7 days post vaccination (day7) |
GSM1147868 | PBMC_232_day-7 |
44 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
232 |
7 days prior to vaccination (day-7) |
GSM1147869 | PBMC_233_day0 |
38 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
40 |
White |
39 |
2000 |
20 |
130 |
38760 |
0 |
0 |
<20 |
0 |
<20 |
233 |
immediately before vaccination (day0) |
GSM1147870 | PBMC_233_day1 |
38 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
233 |
1 day post vaccination (day1) |
GSM1147871 | PBMC_233_day70 |
38 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
160 |
White |
32 |
NA |
40 |
132 |
38624 |
NA |
0 |
80 |
NA |
<20 |
233 |
70 days post vaccination (day70) |
GSM1147872 | PBMC_233_day7 |
38 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
80 |
White |
NA |
2366.5 |
80 |
NA |
NA |
243.5 |
0 |
80 |
906.5 |
<20 |
233 |
7 days post vaccination (day7) |
GSM1147873 | PBMC_233_day-7 |
38 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
233 |
7 days prior to vaccination (day-7) |
GSM1147874 | PBMC_234_day0 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
2 |
80 |
African American |
185 |
1250 |
20 |
338 |
14568 |
16.5 |
2 |
40 |
16.5 |
80 |
234 |
immediately before vaccination (day0) |
GSM1147875 | PBMC_234_day1 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
2 |
NA |
African American |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
234 |
1 day post vaccination (day1) |
GSM1147876 | PBMC_234_day70 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
2 |
5120 |
African American |
134 |
NA |
160 |
215 |
12763 |
NA |
2 |
5120 |
NA |
2560 |
234 |
70 days post vaccination (day70) |
GSM1147877 | PBMC_234_day7 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
2 |
1280 |
African American |
NA |
14933 |
40 |
NA |
NA |
4430 |
2 |
640 |
4436.5 |
1280 |
234 |
7 days post vaccination (day7) |
GSM1147878 | PBMC_234_day-7 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
2 |
NA |
African American |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
234 |
7 days prior to vaccination (day-7) |
GSM1147879 | PBMC_235_day0 |
22 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
40 |
White |
20 |
NA |
40 |
47 |
19667 |
NA |
1 |
80 |
NA |
<20 |
235 |
immediately before vaccination (day0) |
GSM1147880 | PBMC_235_day1 |
22 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
235 |
1 day post vaccination (day1) |
GSM1147881 | PBMC_235_day70 |
22 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
40 |
White |
312 |
NA |
1280 |
957 |
40580 |
NA |
1 |
1280 |
NA |
2560 |
235 |
70 days post vaccination (day70) |
GSM1147882 | PBMC_235_day7 |
22 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
1280 |
White |
NA |
NA |
320 |
NA |
NA |
NA |
1 |
160 |
NA |
320 |
235 |
7 days post vaccination (day7) |
GSM1147883 | PBMC_235_day-7 |
22 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
235 |
7 days prior to vaccination (day-7) |
GSM1147884 | PBMC_236_day0 |
33 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
0 |
640 |
White |
3 |
600 |
1280 |
41 |
34667 |
0 |
0 |
80 |
0 |
<20 |
236 |
immediately before vaccination (day0) |
GSM1147885 | PBMC_236_day1 |
33 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
0 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
236 |
1 day post vaccination (day1) |
GSM1147886 | PBMC_236_day70 |
33 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
0 |
20 |
White |
2 |
NA |
1280 |
30 |
1990 |
NA |
0 |
80 |
NA |
<20 |
236 |
70 days post vaccination (day70) |
GSM1147887 | PBMC_236_day7 |
33 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
0 |
1280 |
White |
NA |
633 |
1280 |
NA |
NA |
320 |
0 |
160 |
25 |
<20 |
236 |
7 days post vaccination (day7) |
GSM1147888 | PBMC_237_day0 |
21 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
640 |
White |
65 |
333 |
40 |
207 |
25510 |
0 |
2 |
160 |
0 |
<20 |
237 |
immediately before vaccination (day0) |
GSM1147889 | PBMC_237_day1 |
21 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
237 |
1 day post vaccination (day1) |
GSM1147890 | PBMC_237_day7 |
21 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
20480 |
White |
NA |
1383 |
320 |
NA |
NA |
5 |
2 |
2560 |
1008.5 |
<20 |
237 |
7 days post vaccination (day7) |
GSM1147891 | PBMC_237_day-7 |
21 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
237 |
7 days prior to vaccination (day-7) |
GSM1147892 | PBMC_241_day0 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
320 |
White |
12 |
617 |
20 |
25 |
19216 |
0 |
2 |
<20 |
0 |
<20 |
241 |
immediately before vaccination (day0) |
GSM1147893 | PBMC_241_day1 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
241 |
1 day post vaccination (day1) |
GSM1147894 | PBMC_241_day70 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
2560 |
White |
59 |
NA |
640 |
363 |
32911 |
NA |
2 |
20 |
NA |
160 |
241 |
70 days post vaccination (day70) |
GSM1147895 | PBMC_241_day7 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
1280 |
White |
NA |
5183 |
320 |
NA |
NA |
130 |
2 |
<20 |
3436.5 |
80 |
241 |
7 days post vaccination (day7) |
GSM1147896 | PBMC_241_day-7 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
241 |
7 days prior to vaccination (day-7) |
GSM1147897 | PBMC_242_day1 |
34 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
242 |
1 day post vaccination (day1) |
GSM1147898 | PBMC_242_day70 |
34 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
5120 |
White |
70 |
NA |
160 |
164 |
14534 |
NA |
1 |
160 |
NA |
160 |
242 |
70 days post vaccination (day70) |
GSM1147899 | PBMC_242_day7 |
34 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
5120 |
White |
NA |
2600 |
320 |
NA |
NA |
283.5 |
1 |
640 |
1901.5 |
160 |
242 |
7 days post vaccination (day7) |
GSM1147900 | PBMC_243_day1 |
21 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
NA |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
243 |
1 day post vaccination (day1) |
GSM1147901 | PBMC_243_day70 |
21 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
NA |
10240 |
White |
194 |
NA |
1280 |
677 |
33333 |
NA |
NA |
5120 |
NA |
160 |
243 |
70 days post vaccination (day70) |
GSM1147902 | PBMC_243_day7 |
21 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
NA |
10240 |
White |
NA |
1750 |
1280 |
NA |
NA |
21.5 |
NA |
2560 |
813.5 |
320 |
243 |
7 days post vaccination (day7) |
GSM1147903 | PBMC_244_day0 |
41 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
20 |
Asain |
5 |
2100 |
<20 |
77 |
43161 |
0 |
1 |
<20 |
0 |
<20 |
244 |
immediately before vaccination (day0) |
GSM1147904 | PBMC_244_day1 |
41 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
244 |
1 day post vaccination (day1) |
GSM1147905 | PBMC_244_day70 |
41 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
2560 |
Asain |
90 |
NA |
40 |
318 |
36928 |
NA |
1 |
160 |
NA |
640 |
244 |
70 days post vaccination (day70) |
GSM1147906 | PBMC_244_day7 |
41 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
2560 |
Asain |
NA |
4383.5 |
80 |
NA |
NA |
1046.5 |
1 |
320 |
943.5 |
640 |
244 |
7 days post vaccination (day7) |
GSM1147907 | PBMC_244_day-7 |
41 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
244 |
7 days prior to vaccination (day-7) |
GSM1147908 | PBMC_245_day0 |
45 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
40 |
White |
15 |
1316.5 |
160 |
117 |
24818 |
0 |
2 |
<20 |
16.5 |
<20 |
245 |
immediately before vaccination (day0) |
GSM1147909 | PBMC_245_day1 |
45 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
245 |
1 day post vaccination (day1) |
GSM1147910 | PBMC_245_day70 |
45 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
5120 |
White |
125 |
NA |
5120 |
489 |
14657 |
NA |
2 |
160 |
NA |
320 |
245 |
70 days post vaccination (day70) |
GSM1147911 | PBMC_245_day7 |
45 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
640 |
White |
NA |
4583.5 |
640 |
NA |
NA |
490 |
2 |
<20 |
2725 |
160 |
245 |
7 days post vaccination (day7) |
GSM1147912 | PBMC_245_day-7 |
45 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
245 |
7 days prior to vaccination (day-7) |
GSM1147913 | PBMC_246_day0 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
80 |
White |
154 |
867 |
320 |
429 |
47566 |
0 |
1 |
1280 |
5 |
1280 |
246 |
immediately before vaccination (day0) |
GSM1147914 | PBMC_246_day1 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
246 |
1 day post vaccination (day1) |
GSM1147915 | PBMC_246_day70 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
1280 |
White |
117 |
NA |
1280 |
349 |
38961 |
NA |
1 |
1280 |
NA |
1280 |
246 |
70 days post vaccination (day70) |
GSM1147916 | PBMC_246_day7 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
1280 |
White |
NA |
1517 |
320 |
NA |
NA |
225 |
1 |
1280 |
705 |
1280 |
246 |
7 days post vaccination (day7) |
GSM1147917 | PBMC_246_day-7 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
246 |
7 days prior to vaccination (day-7) |
GSM1147918 | PBMC_247_day0 |
46 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
NA |
1280 |
Middle Eastern |
13 |
633.5 |
160 |
461 |
61474 |
0 |
NA |
160 |
0 |
<20 |
247 |
immediately before vaccination (day0) |
GSM1147919 | PBMC_247_day1 |
46 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
NA |
NA |
Middle Eastern |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
247 |
1 day post vaccination (day1) |
GSM1147920 | PBMC_247_day70 |
46 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
NA |
640 |
Middle Eastern |
4 |
NA |
160 |
222 |
47059 |
NA |
NA |
160 |
NA |
20 |
247 |
70 days post vaccination (day70) |
GSM1147921 | PBMC_247_day7 |
46 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
NA |
1280 |
Middle Eastern |
NA |
617 |
160 |
NA |
NA |
15 |
NA |
160 |
33.5 |
20 |
247 |
7 days post vaccination (day7) |
GSM1147922 | PBMC_247_day-7 |
46 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
NA |
NA |
Middle Eastern |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
247 |
7 days prior to vaccination (day-7) |
GSM1147923 | PBMC_248_day7 |
35 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
10240 |
White |
NA |
3766.5 |
640 |
NA |
NA |
106.5 |
1 |
1280 |
438.5 |
160 |
248 |
7 days post vaccination (day7) |
GSM1147924 | PBMC_248_day-7 |
35 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
248 |
7 days prior to vaccination (day-7) |
GSM1147925 | PBMC_249_day0 |
34 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
NA |
160 |
White |
7 |
516.5 |
640 |
138 |
80171 |
0 |
NA |
<20 |
0 |
<20 |
249 |
immediately before vaccination (day0) |
GSM1147926 | PBMC_249_day1 |
34 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
NA |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
249 |
1 day post vaccination (day1) |
GSM1147927 | PBMC_249_day70 |
34 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
NA |
10240 |
White |
360 |
NA |
1280 |
943 |
71836 |
NA |
NA |
1280 |
NA |
1280 |
249 |
70 days post vaccination (day70) |
GSM1147928 | PBMC_249_day7 |
34 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
NA |
20480 |
White |
NA |
41000 |
640 |
NA |
NA |
5383.5 |
NA |
640 |
4950 |
2560 |
249 |
7 days post vaccination (day7) |
GSM1147929 | PBMC_249_day-7 |
34 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
NA |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
249 |
7 days prior to vaccination (day-7) |
GSM1147930 | PBMC_250_day0 |
50 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
2 |
<20 |
Asain |
17 |
1783.5 |
<20 |
122 |
69136 |
16.5 |
2 |
<20 |
0 |
<20 |
250 |
immediately before vaccination (day0) |
GSM1147931 | PBMC_250_day1 |
50 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
2 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
250 |
1 day post vaccination (day1) |
GSM1147932 | PBMC_250_day70 |
50 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
2 |
40 |
Asain |
139 |
NA |
640 |
580 |
62405 |
NA |
2 |
1280 |
NA |
20 |
250 |
70 days post vaccination (day70) |
GSM1147933 | PBMC_250_day7 |
50 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
2 |
20 |
Asain |
NA |
13166.5 |
1280 |
NA |
NA |
281.5 |
2 |
1280 |
3033.5 |
<20 |
250 |
7 days post vaccination (day7) |
GSM1147934 | PBMC_250_day-7 |
50 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
2 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
250 |
7 days prior to vaccination (day-7) |
GSM1147935 | PBMC_251_day0 |
46 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
40 |
African American |
21 |
1383 |
80 |
145 |
99422 |
0 |
1 |
40 |
0 |
<20 |
251 |
immediately before vaccination (day0) |
GSM1147936 | PBMC_251_day1 |
46 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
African American |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
251 |
1 day post vaccination (day1) |
GSM1147937 | PBMC_251_day70 |
46 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
1280 |
African American |
84 |
NA |
640 |
980 |
151358 |
NA |
1 |
640 |
NA |
40 |
251 |
70 days post vaccination (day70) |
GSM1147938 | PBMC_251_day7 |
46 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
640 |
African American |
NA |
4350 |
640 |
NA |
NA |
568.5 |
1 |
2560 |
2245 |
640 |
251 |
7 days post vaccination (day7) |
GSM1147939 | PBMC_251_day-7 |
46 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
African American |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
251 |
7 days prior to vaccination (day-7) |
GSM1147940 | PBMC_252_day0 |
38 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
NA |
1280 |
Asain |
15 |
516.5 |
40 |
136 |
53731 |
0 |
NA |
80 |
0 |
<20 |
252 |
immediately before vaccination (day0) |
GSM1147941 | PBMC_252_day1 |
38 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
NA |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
252 |
1 day post vaccination (day1) |
GSM1147942 | PBMC_252_day70 |
38 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
NA |
20480 |
Asain |
79 |
NA |
320 |
461 |
92456 |
NA |
NA |
160 |
NA |
40 |
252 |
70 days post vaccination (day70) |
GSM1147943 | PBMC_252_day7 |
38 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
NA |
10240 |
Asain |
NA |
1317 |
320 |
NA |
NA |
461.5 |
NA |
640 |
1948.5 |
20 |
252 |
7 days post vaccination (day7) |
GSM1147944 | PBMC_252_day-7 |
38 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
NA |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
252 |
7 days prior to vaccination (day-7) |
GSM1147945 | PBMC_254_day0 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
NA |
640 |
White |
22 |
1933.5 |
<20 |
417 |
86028 |
0 |
NA |
320 |
5 |
<20 |
254 |
immediately before vaccination (day0) |
GSM1147946 | PBMC_254_day1 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
NA |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
254 |
1 day post vaccination (day1) |
GSM1147947 | PBMC_254_day70 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
NA |
640 |
White |
11 |
NA |
160 |
170 |
41143 |
NA |
NA |
320 |
NA |
160 |
254 |
70 days post vaccination (day70) |
GSM1147948 | PBMC_254_day7 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
NA |
640 |
White |
NA |
883 |
160 |
NA |
NA |
216.5 |
NA |
320 |
236.5 |
640 |
254 |
7 days post vaccination (day7) |
GSM1147949 | PBMC_254_day-7 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
NA |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
254 |
7 days prior to vaccination (day-7) |
GSM1147950 | PBMC_256_day0 |
21 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
160 |
African American |
22 |
817 |
<20 |
17 |
28387 |
0 |
2 |
160 |
0 |
<20 |
256 |
immediately before vaccination (day0) |
GSM1147951 | PBMC_256_day1 |
21 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
African American |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
256 |
1 day post vaccination (day1) |
GSM1147952 | PBMC_256_day70 |
21 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
1280 |
African American |
187 |
NA |
40 |
513 |
57447 |
NA |
2 |
5120 |
NA |
160 |
256 |
70 days post vaccination (day70) |
GSM1147953 | PBMC_256_day7 |
21 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
2560 |
African American |
NA |
8133.5 |
160 |
NA |
NA |
1335 |
2 |
20480 |
6348.5 |
40 |
256 |
7 days post vaccination (day7) |
GSM1147954 | PBMC_256_day-7 |
21 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
African American |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
256 |
7 days prior to vaccination (day-7) |
GSM1147955 | PBMC_257_day0 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
0 |
1280 |
White |
16 |
766.5 |
640 |
258 |
23423 |
0 |
NA |
5120 |
0 |
<20 |
257 |
immediately before vaccination (day0) |
GSM1147956 | PBMC_257_day1 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
0 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
257 |
1 day post vaccination (day1) |
GSM1147957 | PBMC_257_day70 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
0 |
10240 |
White |
22 |
NA |
640 |
196 |
20450 |
NA |
NA |
2560 |
NA |
80 |
257 |
70 days post vaccination (day70) |
GSM1147958 | PBMC_257_day7 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
0 |
1280 |
White |
NA |
3100 |
640 |
NA |
NA |
840 |
NA |
5120 |
638.5 |
320 |
257 |
7 days post vaccination (day7) |
GSM1147959 | PBMC_257_day-7 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
0 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
257 |
7 days prior to vaccination (day-7) |
GSM1147960 | PBMC_259_day0 |
34 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
20 |
White |
16 |
2800 |
40 |
116 |
67066 |
0 |
0 |
<20 |
0 |
<20 |
259 |
immediately before vaccination (day0) |
GSM1147961 | PBMC_259_day1 |
34 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
259 |
1 day post vaccination (day1) |
GSM1147962 | PBMC_259_day70 |
34 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
20 |
White |
391 |
NA |
320 |
479 |
56818 |
NA |
0 |
40 |
NA |
80 |
259 |
70 days post vaccination (day70) |
GSM1147963 | PBMC_259_day7 |
34 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
40 |
White |
NA |
16366.5 |
1280 |
NA |
NA |
1945 |
0 |
160 |
6360 |
20 |
259 |
7 days post vaccination (day7) |
GSM1147964 | PBMC_259_day-7 |
34 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
259 |
7 days prior to vaccination (day-7) |
GSM1147965 | PBMC_260_day0 |
51 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
40 |
Asain |
138 |
800 |
320 |
261 |
28629 |
0 |
1 |
160 |
0 |
160 |
260 |
immediately before vaccination (day0) |
GSM1147966 | PBMC_260_day1 |
51 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
260 |
1 day post vaccination (day1) |
GSM1147967 | PBMC_260_day70 |
51 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
640 |
Asain |
174 |
NA |
320 |
265 |
25266 |
NA |
1 |
80 |
NA |
320 |
260 |
70 days post vaccination (day70) |
GSM1147968 | PBMC_260_day7 |
51 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
2560 |
Asain |
NA |
1500 |
320 |
NA |
NA |
1595 |
1 |
160 |
225 |
2560 |
260 |
7 days post vaccination (day7) |
GSM1147969 | PBMC_260_day-7 |
51 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
260 |
7 days prior to vaccination (day-7) |
GSM1147970 | PBMC_261_day0 |
62 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
0 |
640 |
White |
27 |
0 |
20 |
139 |
7514 |
0 |
0 |
40 |
0 |
40 |
261 |
immediately before vaccination (day0) |
GSM1147971 | PBMC_261_day1 |
62 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
0 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
261 |
1 day post vaccination (day1) |
GSM1147972 | PBMC_261_day70 |
62 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
0 |
1280 |
White |
77 |
NA |
80 |
352 |
7716 |
NA |
0 |
80 |
NA |
160 |
261 |
70 days post vaccination (day70) |
GSM1147973 | PBMC_261_day7 |
62 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
0 |
1280 |
White |
NA |
483.5 |
80 |
NA |
NA |
78.5 |
0 |
160 |
105 |
160 |
261 |
7 days post vaccination (day7) |
GSM1147974 | PBMC_261_day-7 |
62 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
0 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
261 |
7 days prior to vaccination (day-7) |
GSM1147975 | PBMC_262_day-7 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
2 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
2 |
NA |
NA |
NA |
262 |
7 days prior to vaccination (day-7) |
GSM1147976 | PBMC_263_day0 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
NA |
<20 |
Asain |
7 |
3200 |
<20 |
66 |
26876 |
0 |
NA |
20 |
0 |
<20 |
263 |
immediately before vaccination (day0) |
GSM1147977 | PBMC_263_day1 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
NA |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
263 |
1 day post vaccination (day1) |
GSM1147978 | PBMC_263_day70 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
NA |
40 |
Asain |
101 |
NA |
320 |
367 |
19463 |
NA |
NA |
1280 |
NA |
20 |
263 |
70 days post vaccination (day70) |
GSM1147979 | PBMC_263_day7 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
NA |
40 |
Asain |
NA |
11700 |
320 |
NA |
NA |
603.5 |
NA |
1280 |
5733.5 |
<20 |
263 |
7 days post vaccination (day7) |
GSM1147980 | PBMC_263_day-7 |
23 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
NA |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
263 |
7 days prior to vaccination (day-7) |
GSM1147981 | PBMC_265_day0 |
30 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
10240 |
White |
42 |
566.5 |
160 |
180 |
54386 |
0 |
NA |
160 |
0 |
20 |
265 |
immediately before vaccination (day0) |
GSM1147982 | PBMC_265_day1 |
30 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
265 |
1 day post vaccination (day1) |
GSM1147983 | PBMC_265_day70 |
30 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
640 |
White |
197 |
NA |
1280 |
1192 |
57576 |
NA |
NA |
320 |
NA |
1280 |
265 |
70 days post vaccination (day70) |
GSM1147984 | PBMC_265_day7 |
30 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
10240 |
White |
NA |
1883 |
5120 |
NA |
NA |
961.5 |
NA |
1280 |
2088.5 |
8000 |
265 |
7 days post vaccination (day7) |
GSM1147985 | PBMC_265_day-7 |
30 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
265 |
7 days prior to vaccination (day-7) |
GSM1147986 | PBMC_267_day0 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
0 |
20480 |
Asain |
77 |
966.5 |
640 |
1260 |
29167 |
0 |
NA |
5120 |
0 |
<20 |
267 |
immediately before vaccination (day0) |
GSM1147987 | PBMC_267_day1 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
0 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
267 |
1 day post vaccination (day1) |
GSM1147988 | PBMC_267_day70 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
0 |
10240 |
Asain |
383 |
NA |
640 |
937 |
26171 |
NA |
NA |
5120 |
NA |
160 |
267 |
70 days post vaccination (day70) |
GSM1147989 | PBMC_267_day7 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
0 |
10240 |
Asain |
NA |
3983.5 |
640 |
NA |
NA |
211.5 |
NA |
5120 |
141.5 |
160 |
267 |
7 days post vaccination (day7) |
GSM1147990 | PBMC_267_day-7 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
0 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
267 |
7 days prior to vaccination (day-7) |
GSM1147991 | PBMC_268_day0 |
34 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
0 |
320 |
White |
7 |
1633.5 |
20 |
13 |
15333 |
0 |
0 |
40 |
0 |
<20 |
268 |
immediately before vaccination (day0) |
GSM1147992 | PBMC_268_day1 |
34 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
0 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
268 |
1 day post vaccination (day1) |
GSM1147993 | PBMC_268_day70 |
34 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
0 |
640 |
White |
54 |
NA |
80 |
93 |
11275 |
NA |
0 |
160 |
NA |
<20 |
268 |
70 days post vaccination (day70) |
GSM1147994 | PBMC_268_day7 |
34 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
0 |
640 |
White |
NA |
983.33335 |
160 |
NA |
NA |
10 |
0 |
320 |
341.66665 |
<20 |
268 |
7 days post vaccination (day7) |
GSM1147995 | PBMC_268_day-7 |
34 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
0 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
268 |
7 days prior to vaccination (day-7) |
GSM1147996 | PBMC_270_day0 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
NA |
80 |
Asain |
20 |
950 |
<20 |
135 |
30061 |
0 |
NA |
80 |
0 |
<20 |
270 |
immediately before vaccination (day0) |
GSM1147997 | PBMC_270_day1 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
NA |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
270 |
1 day post vaccination (day1) |
GSM1147998 | PBMC_270_day70 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
NA |
160 |
Asain |
203 |
NA |
40 |
407 |
50407 |
NA |
NA |
2560 |
NA |
40 |
270 |
70 days post vaccination (day70) |
GSM1147999 | PBMC_270_day7 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
NA |
160 |
Asain |
NA |
4200 |
40 |
NA |
NA |
165 |
NA |
5120 |
2840 |
40 |
270 |
7 days post vaccination (day7) |
GSM1148000 | PBMC_270_day-7 |
23 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
NA |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
270 |
7 days prior to vaccination (day-7) |
GSM1148001 | PBMC_272_day0 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
40 |
White |
10 |
867 |
<20 |
27 |
17544 |
0 |
1 |
160 |
0 |
<20 |
272 |
immediately before vaccination (day0) |
GSM1148002 | PBMC_272_day1 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
272 |
1 day post vaccination (day1) |
GSM1148003 | PBMC_272_day70 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
2560 |
White |
105 |
NA |
40 |
254 |
18029 |
NA |
1 |
1280 |
NA |
320 |
272 |
70 days post vaccination (day70) |
GSM1148004 | PBMC_272_day7 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
2560 |
White |
NA |
9316.835 |
20 |
NA |
NA |
1983.3335 |
1 |
640 |
3145 |
640 |
272 |
7 days post vaccination (day7) |
GSM1148005 | PBMC_272_day-7 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
272 |
7 days prior to vaccination (day-7) |
GSM1148006 | PBMC_273_day0 |
39 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
0 |
1280 |
African American |
17 |
983.5 |
160 |
181 |
9048 |
0 |
0 |
320 |
0 |
<20 |
273 |
immediately before vaccination (day0) |
GSM1148007 | PBMC_273_day1 |
39 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
0 |
NA |
African American |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
273 |
1 day post vaccination (day1) |
GSM1148008 | PBMC_273_day70 |
39 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
0 |
2560 |
African American |
57 |
NA |
320 |
90 |
10638 |
NA |
0 |
1280 |
NA |
<20 |
273 |
70 days post vaccination (day70) |
GSM1148009 | PBMC_273_day7 |
39 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
0 |
2560 |
African American |
NA |
667 |
320 |
NA |
NA |
90 |
0 |
1280 |
431.5 |
<20 |
273 |
7 days post vaccination (day7) |
GSM1148010 | PBMC_273_day-7 |
39 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
0 |
NA |
African American |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
273 |
7 days prior to vaccination (day-7) |
GSM1148011 | PBMC_274_day70 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
1280 |
White |
28 |
NA |
160 |
120 |
16898 |
NA |
1 |
2560 |
NA |
320 |
274 |
70 days post vaccination (day70) |
GSM1148012 | PBMC_274_day-7 |
24 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
274 |
7 days prior to vaccination (day-7) |
GSM1148013 | PBMC_275_day0 |
27 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
NA |
20 |
White |
0 |
1799.83335 |
<20 |
0 |
16850 |
0 |
NA |
<20 |
0 |
<20 |
275 |
immediately before vaccination (day0) |
GSM1148014 | PBMC_275_day1 |
27 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
NA |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
275 |
1 day post vaccination (day1) |
GSM1148015 | PBMC_275_day-7 |
27 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
NA |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
275 |
7 days prior to vaccination (day-7) |
GSM1148016 | PBMC_277_day0 |
53 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
0 |
640 |
Asain |
22 |
1267 |
320 |
160 |
20258 |
33.5 |
0 |
640 |
5 |
<20 |
277 |
immediately before vaccination (day0) |
GSM1148017 | PBMC_277_day1 |
53 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
0 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
277 |
1 day post vaccination (day1) |
GSM1148018 | PBMC_277_day70 |
53 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
0 |
2560 |
Asain |
117 |
NA |
640 |
372 |
12216 |
NA |
0 |
2560 |
NA |
160 |
277 |
70 days post vaccination (day70) |
GSM1148019 | PBMC_277_day7 |
53 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
0 |
5120 |
Asain |
NA |
4350 |
320 |
NA |
NA |
1310 |
0 |
1280 |
1071.5 |
320 |
277 |
7 days post vaccination (day7) |
GSM1148020 | PBMC_277_day-7 |
53 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
0 |
NA |
Asain |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
277 |
7 days prior to vaccination (day-7) |
GSM1148021 | PBMC_279_day0 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
0 |
80 |
White |
44 |
1400 |
80 |
264 |
38462 |
0 |
0 |
640 |
16.5 |
<20 |
279 |
immediately before vaccination (day0) |
GSM1148022 | PBMC_279_day1 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
0 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
279 |
1 day post vaccination (day1) |
GSM1148023 | PBMC_279_day70 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
0 |
320 |
White |
96 |
NA |
320 |
548 |
30594 |
NA |
0 |
1280 |
NA |
40 |
279 |
70 days post vaccination (day70) |
GSM1148024 | PBMC_279_day-7 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
0 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
0 |
NA |
NA |
NA |
279 |
7 days prior to vaccination (day-7) |
GSM1148025 | PBMC_280_day0 |
44 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
40 |
Hispanic |
10 |
1566.5 |
<20 |
54 |
17289 |
0 |
1 |
<20 |
0 |
<20 |
280 |
immediately before vaccination (day0) |
GSM1148026 | PBMC_280_day1 |
44 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
Hispanic |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
280 |
1 day post vaccination (day1) |
GSM1148027 | PBMC_280_day70 |
44 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
2560 |
Hispanic |
43 |
NA |
80 |
245 |
17664 |
NA |
1 |
80 |
NA |
40 |
280 |
70 days post vaccination (day70) |
GSM1148028 | PBMC_280_day7 |
44 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
1280 |
Hispanic |
NA |
2583.5 |
320 |
NA |
NA |
225 |
1 |
20 |
1798.5 |
320 |
280 |
7 days post vaccination (day7) |
GSM1148029 | PBMC_280_day-7 |
44 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
Hispanic |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
280 |
7 days prior to vaccination (day-7) |
GSM1148030 | PBMC_281_day0 |
44 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
NA |
160 |
White |
63 |
600 |
160 |
296 |
41815 |
0 |
NA |
80 |
33.5 |
<20 |
281 |
immediately before vaccination (day0) |
GSM1148031 | PBMC_281_day1 |
44 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
NA |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
281 |
1 day post vaccination (day1) |
GSM1148032 | PBMC_281_day70 |
44 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
NA |
40 |
White |
82 |
NA |
80 |
228 |
40741 |
NA |
NA |
160 |
NA |
160 |
281 |
70 days post vaccination (day70) |
GSM1148033 | PBMC_281_day7 |
44 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
NA |
80 |
White |
NA |
1700 |
160 |
NA |
NA |
980 |
NA |
80 |
590 |
160 |
281 |
7 days post vaccination (day7) |
GSM1148034 | PBMC_281_day-7 |
44 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
NA |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
281 |
7 days prior to vaccination (day-7) |
GSM1148035 | PBMC_282_day0 |
39 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
NA |
640 |
White |
26 |
1750 |
320 |
63 |
17018 |
0 |
NA |
1280 |
0 |
640 |
282 |
immediately before vaccination (day0) |
GSM1148036 | PBMC_282_day1 |
39 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
NA |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
282 |
1 day post vaccination (day1) |
GSM1148037 | PBMC_282_day70 |
39 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
NA |
1280 |
White |
84 |
NA |
640 |
248 |
20160 |
NA |
NA |
1280 |
NA |
1280 |
282 |
70 days post vaccination (day70) |
GSM1148038 | PBMC_282_day7 |
39 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
NA |
10240 |
White |
NA |
3400 |
640 |
NA |
NA |
963.5 |
NA |
2560 |
818.5 |
1280 |
282 |
7 days post vaccination (day7) |
GSM1148039 | PBMC_282_day-7 |
39 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
NA |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
282 |
7 days prior to vaccination (day-7) |
GSM1148040 | PBMC_283_day0 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 0 |
1 |
320 |
White |
26 |
1266.5 |
160 |
338 |
58372 |
0 |
1 |
1280 |
0 |
<20 |
283 |
immediately before vaccination (day0) |
GSM1148041 | PBMC_283_day1 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 1 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
283 |
1 day post vaccination (day1) |
GSM1148042 | PBMC_283_day70 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 70 |
1 |
20480 |
White |
199 |
NA |
320 |
607 |
55408 |
NA |
1 |
2560 |
NA |
40 |
283 |
70 days post vaccination (day70) |
GSM1148043 | PBMC_283_day7 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day 7 |
1 |
1280 |
White |
NA |
1983.5 |
160 |
NA |
NA |
36.5 |
1 |
1280 |
2110 |
<20 |
283 |
7 days post vaccination (day7) |
GSM1148044 | PBMC_283_day-7 |
22 |
female |
peripheral blood mononuclear cells (PBMC) |
day -7 |
1 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
283 |
7 days prior to vaccination (day-7) |
GSM1148045 | PBMC_284_day0 |
28 |
male |
peripheral blood mononuclear cells (PBMC) |
day 0 |
2 |
80 |
White |
21 |
1150 |
<20 |
21 |
24479 |
0 |
1 |
<20 |
0 |
<20 |
284 |
immediately before vaccination (day0) |
GSM1148046 | PBMC_284_day1 |
28 |
male |
peripheral blood mononuclear cells (PBMC) |
day 1 |
2 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
284 |
1 day post vaccination (day1) |
GSM1148047 | PBMC_284_day70 |
28 |
male |
peripheral blood mononuclear cells (PBMC) |
day 70 |
2 |
5120 |
White |
239 |
NA |
40 |
484 |
60177 |
NA |
1 |
640 |
NA |
1280 |
284 |
70 days post vaccination (day70) |
GSM1148048 | PBMC_284_day7 |
28 |
male |
peripheral blood mononuclear cells (PBMC) |
day 7 |
2 |
20480 |
White |
NA |
11466.835 |
160 |
NA |
NA |
933.3335 |
1 |
640 |
4233.3335 |
640 |
284 |
7 days post vaccination (day7) |
GSM1148049 | PBMC_284_day-7 |
28 |
male |
peripheral blood mononuclear cells (PBMC) |
day -7 |
2 |
NA |
White |
NA |
NA |
NA |
NA |
NA |
NA |
1 |
NA |
NA |
NA |
284 |
7 days prior to vaccination (day-7) |
Name | ||
---|---|---|
All Samples | Default | View |
In order to make new Group Sets or change settings, please log in. |
Group Set | |
---|---|
All Samples |